Barclays’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,355,500
Closed -$10.4M 5441
2024
Q3
$10.4M Buy
+1,355,500
New +$12.5M ﹤0.01% 1466
2020
Q3
Sell
-1,600
Closed -$6K 5500
2020
Q2
$6K Sell
1,600
-400
-20% -$1.38K ﹤0.01% 5378
2020
Q1
$5K Buy
2,000
+1,300
+186% +$8.41K ﹤0.01% 5938
2019
Q4
$7K Sell
700
-3,700
-84% -$33.5K ﹤0.01% 6139
2019
Q3
$38K Sell
4,400
-30,300
-87% -$297K ﹤0.01% 6017
2019
Q2
$399K Buy
34,700
+22,400
+182% +$288K ﹤0.01% 4530
2019
Q1
$172K Sell
12,300
-4,500
-27% -$59K ﹤0.01% 4938
2018
Q4
$174K Buy
16,800
+1,700
+11% +$25.1K ﹤0.01% 4666
2018
Q3
$258K Buy
15,100
+4,900
+48% +$84.2K ﹤0.01% 4797
2018
Q2
$184K Sell
10,200
-4,900
-32% -$98.2K ﹤0.01% 4790
2018
Q1
$264K Sell
15,100
-3,700
-20% -$77.2K ﹤0.01% 4575
2017
Q4
$433K Sell
18,800
-23,600
-56% -$489K ﹤0.01% 4005
2017
Q3
$888K Sell
42,400
-100
-0.2% -$1.84K ﹤0.01% 3107
2017
Q2
$858K Buy
42,500
+39,000
+1,114% +$850K ﹤0.01% 3019
2017
Q1
$85K Sell
3,500
-4,900
-58% -$132K ﹤0.01% 5005
2016
Q4
$226K Buy
8,400
+2,600
+45% +$64.2K ﹤0.01% 4129
2016
Q3
$130K Sell
5,800
-90,800
-94% -$1.82M ﹤0.01% 4317
2016
Q2
$2.06M Buy
96,600
+91,600
+1,832% +$1.73M ﹤0.01% 1983
2016
Q1
$85K Buy
5,000
+4,900
+4,900% +$73.1K ﹤0.01% 4461
2015
Q4
$2K Sell
100
-3,400
-97% -$52.3K ﹤0.01% 5759
2015
Q3
$46K Sell
3,500
-7,300
-68% -$116K ﹤0.01% 5056
2015
Q2
$194K Buy
10,800
+4,000
+59% +$83K ﹤0.01% 4165
2015
Q1
$122K Sell
6,800
-6,100
-47% -$105K ﹤0.01% 4717
2014
Q4
$206K Buy
12,900
+9,500
+279% +$200K ﹤0.01% 4612
2014
Q3
$109K Sell
3,400
-6,000
-64% -$204K ﹤0.01% 5254
2014
Q2
$319K Sell
9,400
-800
-8% -$26.3K ﹤0.01% 4394
2014
Q1
$316K Buy
10,200
+4,200
+70% +$117K ﹤0.01% 4356
2013
Q4
$150K Buy
6,000
+1,900
+46% +$45.5K ﹤0.01% 5285
2013
Q3
$86K Sell
4,100
-48,200
-92% -$990K ﹤0.01% 5738
2013
Q2
$1.01M Buy
+52,300
New +$1.14M ﹤0.01% 3333

Other funds holding PTEN

Barclays's PTEN Position: Q1 2026 in Review

Barclays increased its Patterson-UTI (PTEN) stake by 75% in Q1 2026, buying an estimated $7.17M and bringing the position to 1,956,581 shares worth $21.2M. The position accounts for 0.01% of the portfolio, ranked #1073.

Barclays first reported a position in PTEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $27.3M in Q2 2024. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Barclays held 1,956,581 shares of Patterson-UTI worth $21.2M as of Q1 2026.
  • Barclays bought 838,091 Patterson-UTI shares in Q1 2026, an estimated $7.17M.
  • Patterson-UTI made up 0.01% of Barclays's portfolio in Q1 2026, its #1073 holding.
  • Barclays first reported a position in Patterson-UTI in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Patterson-UTI position peaked at $27.3M in Q2 2024.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.